TABLE 3.
Details of curcumin’s role in inflammatory bowel disease treatment in vitro.
Cell line | Dose (μM) | Effects on biomarkers | Pathways involved | Ref. |
---|---|---|---|---|
IEC-6, HT-29, CACO-2 | 0–150 | NF-κB↓ | the IκB/NF-κB pathway | Jobin et al. (1999) |
Colonic epithelial cells (CEC), peritoneal macrophage, young adult mouse colonocytes cells (YAMC) | 50 | PI3K activity↓AKT phosphorylation↓F-actin polymerization↓MIP-2↓KC↓IL-1β↓MIP-1α↓ | PI3K/AKT pathway | Larmonier et al. (2011) |
Colonic myofibroblasts (CMF) | 0–30 | p38 MAPK↓NF-κB (-)MMP-3↓IL-1β↓IL-10↑ | MAPK p38 pathway | Epstein et al. (2010b) |
BM-derived dendritic cell (BMDC) | 1–100 | IL-10↑NF-κB↓IL-6↓TNF-α↓ | NF-κB pathway | Cong et al. (2009) |
T-84 cells, young adult mouse colonocytes cells (YAMC) | 0–75 | IFN- γ ↓CIITA↓ | Jak-Stat signaling pathway | Midura-Kiela et al. (2012) |